Biology Insights

Does Bacterial Vaginosis Mean My Partner Cheated?

Separate fact from fear. We clarify if Bacterial Vaginosis is truly an STI and what causes this common vaginal imbalance.

By Paloma Kerr

Bacterial vaginosis does not mean your partner cheated on you. BV is not a sexually transmitted infection in the traditional sense. It is a shift in the vaginal microbiome, not an invasion by a single pathogen passed from one person to another the way chlamydia or gonorrhea would be. That said, the relationship between BV and sexual activity is real and complicated enough that the worry about infidelity is one of the most common reactions women report after a diagnosis.

What Is Actually Happening During BV

A healthy vaginal environment is typically dominated by Lactobacillus bacteria, which produce lactic acid and keep the pH low. BV happens when that balance tips and a diverse mix of other bacteria takes over. It primarily affects women of reproductive age, and the hallmark symptoms are a thin grayish-white discharge and a fishy odor, though many women with BV have no symptoms at all.

This distinction matters because with a classic STI, you can point to a specific organism that one partner carried and gave to the other. BV doesn’t work that way. The bacteria involved, like Gardnerella vaginalis and Prevotella species, are often already present in small numbers in a perfectly healthy vagina. The problem is the collapse of the Lactobacillus population and the overgrowth of those other organisms. Think of it less like catching a cold and more like a garden getting overrun by weeds that were always in the soil.

Why Sex Gets Blamed

Sex is a genuine risk factor for BV, but not because your partner brought you a specific infection. Researchers have proposed calling BV a “sexually enhanced disease” rather than a sexually transmitted one, because the frequency of intercourse itself appears to be a critical factor, not necessarily who the partner is or how many partners someone has had.

One of the clearest mechanisms involves semen. The vagina is naturally acidic, with a pH around 3.5 to 4.5. Semen is alkaline, with a pH around 7 to 8. After unprotected sex, semen temporarily neutralizes vaginal acidity, and research has shown that traces of semen can linger and keep the pH elevated. Vaginal Lactobacilli can reacidify the environment afterward, but this takes time. If sex is frequent, the vaginal pH may stay elevated for extended periods, creating a window in which BV-associated bacteria can gain a foothold. One study found that recent semen exposure roughly doubled the risk of BV, after adjusting for age, contraceptive use, and condom use.

So a woman can develop BV from regular sex with her long-term, faithful partner. A new sexual partner can trigger it. A return to sex after a dry spell can trigger it. The relevant variable is the act itself and its biochemical consequences, not infidelity.

The Male Partner’s Bacteria Do Play a Role

Here is where the picture gets more nuanced. Studies of monogamous heterosexual couples have found that men whose partners have BV carry significantly more BV-associated bacteria on their penile skin and in their urethra than men whose partners have a healthy vaginal microbiome. In those couples, the man’s penile microbiota more closely resembled his partner’s vaginal bacteria than the vaginal bacteria of other women with BV. Research in Kenyan couples identified specific bacterial species on the penis, including Dialister and Megasphaera, that were associated with increased odds of BV in the female partner.

This means there is some bacterial exchange happening between sexual partners. But again, this doesn’t require infidelity. A couple can essentially share and re-share a microbial community between them, creating a cycle where the same BV-associated bacteria keep bouncing back and forth. This is one of the key reasons BV recurs so often after treatment, and it’s why researchers are now studying whether treating the male partner could break that cycle.

Plenty of Non-Sexual Triggers

If BV were purely about sex, you’d expect celibate women to never get it. They do. Several well-documented factors can destabilize the vaginal microbiome on their own.

Hormonal changes, new soaps, certain types of underwear, and smoking have also been implicated. The point is that BV has many doors in, and sex is just one of them.

Evidence from Women Who Have Sex with Women

Some of the strongest evidence that BV involves bacterial exchange between sexual partners comes from research on women who have sex with women. In monogamous lesbian couples, if one partner had BV, the other partner was about 20 times more likely to also have it compared to couples where neither had BV. A larger study found that having a partner with BV was strongly associated with BV in the other woman, and sharing sex toys in the prior three months also appeared to elevate risk.

This data reinforces the idea that BV-associated bacteria can be transferred between partners during sexual contact. But it also reinforces that the transfer doesn’t depend on a new or outside partner. Monogamous couples in stable relationships show the highest concordance, precisely because they share a microbiome over time.

Genetics and Individual Susceptibility

One thing that often gets lost in conversations about BV is that some people are simply more prone to it than others, regardless of their sexual behavior. Racial disparities in BV prevalence persist even after adjusting for differences in sexual practices, which suggests a genetic component. Researchers have identified specific gene variants in mucosal defense pathways, including toll-like receptors and cytokines, that are associated with BV risk across different ancestral groups. Interferon signaling pathways may also influence which bacteria can thrive in the vaginal environment.

In practical terms, this means two women with identical sexual histories and hygiene habits can have very different BV experiences. Some women never get it. Others deal with it repeatedly no matter what they do. Blaming a partner, or yourself, for something that may be partly hardwired into your immune response is unfair and unhelpful.

Why BV Keeps Coming Back

Recurrence is the defining frustration of BV. Roughly half of women who are treated for BV experience a recurrence within a year. Standard treatment with oral metronidazole achieves about an 80 percent cure rate at 30 days, but the condition frequently returns after that.

A major reason is biofilm. BV-associated bacteria, particularly Gardnerella vaginalis and Atopobium vaginae, form a dense, sticky layer on the vaginal lining. Even when antibiotics kill the free-floating bacteria, research has shown that this biofilm persists and bounces back after treatment ends. The biofilm essentially acts as a shelter, protecting the bacteria from antibiotics and from the body’s own defenses. This means the BV was never really gone; it was hiding.

This is worth emphasizing for anyone whose BV returned and immediately suspected their partner: the single most common reason for recurrence is the persistence of bacteria that were already there, not a new exposure from anyone.

Does Treating the Male Partner Help

Because male partners can harbor BV-associated bacteria, the obvious question is whether treating them simultaneously would reduce recurrence. This has been debated for years, and the evidence is now genuinely mixed.

A randomized trial published in the New England Journal of Medicine tested combined oral and topical antimicrobial treatment for male partners alongside standard treatment for women. Recurrence within 12 weeks was about 35 percent in the partner-treatment group compared to 63 percent in the group where only the woman was treated. That is a striking difference and generated a lot of excitement.

However, a systematic review and meta-analysis pooling data from multiple randomized trials found no significant overall reduction in BV recurrence with male partner treatment compared to standard female-only therapy. The discrepancy likely comes down to differences in the specific treatment regimens used. The NEJM trial used a particular combination of oral and penile antibiotics that other trials did not replicate. Simply handing a man a course of the same antibiotic his partner takes may not be enough, because penile bacteria live on skin and in the urethra, environments that may need different approaches.

Current guidelines generally do not recommend routine male partner treatment for BV, though this is an active area of research. If you are dealing with recurrent BV, it is worth discussing the latest evidence with your doctor, because recommendations may shift as more targeted partner-treatment strategies are studied.

The Emotional Weight of a BV Diagnosis

The fear that a partner has been unfaithful is one of the first things many women feel when they are diagnosed. Qualitative research has found that women with recurrent BV commonly experience embarrassment, shame, and a sense of being “dirty,” and that confusion about the cause is one of the hardest aspects of the condition. One participant in a study put it plainly: “Everything was running through my head, is it the Mirena coil? Has my boyfriend cheated on me and given me something? Have I done something wrong?”

The stigma is compounded by the fact that BV symptoms overlap with those of some STIs, and the vague way it is sometimes communicated by healthcare providers leaves many women filling in the blanks with the worst-case scenario. Research has found that single women who attributed their BV to casual or unprotected sex were more likely to blame themselves, while women in stable relationships who framed it as “just one of those things” coped better emotionally. The framing matters, and understanding that BV is a microbial imbalance with many triggers, not evidence of cheating, can meaningfully reduce the emotional burden.

BV and Vulnerability to Other Infections

One reason BV deserves attention beyond the immediate symptoms is that it makes the body more vulnerable to other infections. BV disrupts the vaginal lining’s barrier function and triggers an inflammatory response that can actually make it easier for viruses and other pathogens to gain entry. A meta-analysis of published studies found that women with BV had about a 60 percent higher risk of acquiring HIV. The risk also runs in the other direction: among HIV-positive women, those with BV were roughly three times more likely to transmit the virus to a male partner.

BV has also been associated with increased susceptibility to herpes simplex virus, chlamydia, and gonorrhea, and with complications in pregnancy including preterm birth. None of this is meant to alarm you, but it does underscore that getting BV treated and keeping it from recurring is worthwhile for reasons beyond the unpleasant symptoms.

Why Humans Are Unusually Prone to BV

There is an interesting evolutionary wrinkle to all of this. Humans are unusual among primates in having vaginal communities dominated by Lactobacillus. Other primates have much more diverse vaginal microbiomes without the strong acid-producing Lactobacillus dominance that we consider “healthy” in humans. Researchers have hypothesized that this uniquely human trait evolved alongside our unusual reproductive biology, including continuous sexual receptivity and the tight fit between the neonatal head and the birth canal, which creates elevated infection risks during birth. A Lactobacillus-dominated, acidic vaginal environment may have been selected for because it minimizes the risk of infection during sex, pregnancy, and delivery.

The downside of depending so heavily on one group of bacteria is that the system is fragile. Anything that disrupts Lactobacillus, whether it’s semen, menstrual blood, antibiotics, stress, or genetics, can tip the balance. BV may be the cost of an evolutionary strategy that works brilliantly most of the time but leaves little margin for error. That fragility, not your partner’s behavior, is the real reason BV is so common.

Related Content

More in Reproductive